Roche, Chugai amend licensing deal

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said it and majority owner Roche (SIX:ROG; OTCQX:RHHBY) amended an agreement covering the geographic regions and timing of Roche's first refusal rights to Chugai compounds. Under the amended deal, Roche has worldwide first refusal rights to Chugai compounds, excluding Japan, South Korea and Taiwan. The pharma also will have first refusal rights to Chugai compounds at early proof of concept. The companies did not change Chugai's right of first refusal to Roche's products in Japan. ...